Bill Gates' Foundation Invests In The Future Of HIV Prevention

Bill Gates' foundation invests up to $140 million for a new HIV-prevention therapy.
SMS
Bill Gates' Foundation Invests In The Future Of HIV Prevention

The Bill & Melinda Gates Foundation plans to invest up to $140 million into a company to further its work on an innovative HIV-prevention treatment.

The drug should work similarly to a diabetes treatment the company, Intarcia Therapeutics, is currently working on. Patients would have a small pump inserted into their abdomen that would deliver HIV-prevention medicine over the course of six months or one year.

The treatment is likely years away from being approved, but it could prove to be a lot more effective than other HIV-prevention measures simply because people don't have to remember to take it every day.

This is yet another recent breakthrough in the fight against HIV/AIDS. Advocates say 2016 has been a great year for the science of HIV prevention. 

Several studies across the world are testing new HIV cures and preventative injections.

But there's still a lot of work to be done. Nearly 2 million people are infected annually. An epidemic in Russia alone reportedly saw 100,000 new cases in 2016.

Featured Stories
Marchers for science in Washington, D.C.

What Motivates People To March For Science?

Marine Le Pen during her presidential campaign

Everything You Need To Know About France's Presidential Election

Donald Trump

The US Will Honor An Obama-Era Refugee Deal Trump Once Called 'Dumb'